0001179110-12-013325.txt : 20120824 0001179110-12-013325.hdr.sgml : 20120824 20120824183912 ACCESSION NUMBER: 0001179110-12-013325 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120824 FILED AS OF DATE: 20120824 DATE AS OF CHANGE: 20120824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BUCHEN DAVID A CENTRAL INDEX KEY: 0001241751 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 121055447 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 edgar.xml FORM 4 - X0306 4 2012-08-24 0 0000884629 WATSON PHARMACEUTICALS INC WPI 0001241751 BUCHEN DAVID A MORRIS CORPORATE CENTER III 400 INTERPACE PKWY PARSIPPANY NJ 07054 0 1 0 0 Chief Legal Officer-Global&Sec Common Stock, par value $0.0033 2012-08-24 4 M 0 24294 29.43 A 110327 D Common Stock, par value $0.0033 2012-08-24 4 M 0 706 29.43 A 111033 D Common Stock, par value $0.0033 2012-08-24 4 S 0 24294 81.56 D 86739 D Non-Qualified Options to Purchase Common Stock 29.43 2012-08-24 4 M 0 24294 0 D 2007-11-20 2012-11-20 Common Stock, par value $0.0033 24294 0 D Incentive Stock Options to Purchase Common Stock 29.43 2012-08-24 4 M 0 706 0 D 2007-11-20 2012-11-20 Common Stock, par value $0.0033 706 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.51 to $81.80, inclusive. The reporting person undertakes to provide to Watson Pharmaceuticals, Inc., any security holder of Watson Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. /s/DAVID A. BUCHEN 2012-08-24